Related Experiment Videos
Analysis of low-dose benzodiazepines by HPLC with automated solid-phase extraction
K K Akerman1, J Jolkkonen, M Parviainen
1Department of Clinical Chemistry, Kuopio University Hospital, Finland. Kari.okerman@messi.uku.fi
Clinical Chemistry
|September 1, 1996
Summary
This study presents a precise HPLC method for measuring benzodiazepine drug levels in human serum. The validated assay is suitable for clinical use in therapeutic drug monitoring.
Area of Science:
- Analytical Chemistry
- Clinical Chemistry
- Pharmacology
Background:
- Accurate quantification of benzodiazepines is crucial for therapeutic drug monitoring.
- Existing methods may lack the specificity or sensitivity required for clinical applications.
Purpose of the Study:
- To develop and validate a simple, specific, and sensitive high-performance liquid chromatography (HPLC) method.
- To enable accurate measurement of alprazolam, clonazepam, and nitrazepam in human serum or plasma.
Main Methods:
- Automated solid-phase extraction (SPE) using C18 columns for sample preparation.
- Isocratic elution HPLC with a diode-array detector for drug separation and detection.
- Validation of the method for recovery, precision, and specificity.
Main Results:
- High recoveries (94-100%) and low coefficients of variation (CVs) for intra-assay (1.0-4.1%) and inter-assay (1.0-4.1%).
- A sensitive detection limit of 5 nmol/L was achieved.
- No interference observed from common antiepileptic and antidepressant drugs.
Conclusions:
- The developed HPLC method is reliable for quantifying benzodiazepines in biological matrices.
- This assay is well-suited for routine clinical laboratory use in therapeutic drug monitoring.
- The method offers a robust tool for optimizing patient treatment with these medications.